(Euronext Growth Paris:ALGBE), PRESS RELEASE Global Bioenergies: postponement of the takeover offers review hearing to 24 November Evry, 04 November 2025 – 05:45 p.m: The hearing which was held yesterday at the Commercial Court of Evry concluded with the decision to postpone until 24 November 2025 the review of the offers to take over Global […]
(Paris:TNG), New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] patients Comprehensive immunogenicity data demonstrate TG4050's ability to induce neoantigen-specific cytotoxic CD8+ T cell responses capable of targeting and eliminating tumor cells, supporting its potential to reduce risk of relapse Conference call scheduled on
Global Bioenergies: postponement of the takeover offers review hearing to 24 November GlobeNewswire November 04, 2025 PRESS RELEASE Global Bioenergies: postponement of the takeover offers review hearing to 24 November Evry, 04 November 2025 – 05:45 p.m: The hearing which was held yesterday at the Commercial Court of Evry concluded with the decision to postpone
New Phase I Immunological Data Presented at SITC 2025 Support TG4050's Potential Role in Preventing Cancer Relapse GlobeNewswire November 04, 2025 New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] patients Comprehensive immunogenicity data demonstrate TG4050's ability to induce neoantigen-specific cytotoxic CD8+ T cell
(Other OTC:NJDCY), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Nidec To Contact Him Directly To Discuss Their Options If you suffered significant losses in Nidec stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at
NJDCY INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec GlobeNewswire November 04, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Nidec To Contact Him Directly To Discuss Their Options If you suffered significant losses in Nidec stock or options
(NASDAQ:DXCM), NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between July 26, 2024 and September 17, 2025, both dates inclusive (the “Class Period”) of the important December 29, 2025 lead plaintiff deadline. SO WHAT: If you
(NYSE:BAX), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $10,000 In Baxter To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $10,000 in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi &
Annual award recognizes excellence in recall management among healthcare institutions worldwide ECRI, a global patient safety nonprofit organization, announced the winners of its 2025 Alerts Impact Award, which recognizesECRI Alerts Workflow members for excellence in recall management. The annual award highlights the importance of recall management in ensuring the continuity of safe, high-quality healthcare. https://mma.prnewswire.com/media/1980786/ECRI_Logo_2025.jpg
As the leader in cloud-based and innovative business solutions for dentists and their teams, Curve's expanding offering will further simplify, streamline, and strengthen performance for dental practices nationwide Curve Dental®, the leading provider of all-in-one, cloud-based dental practice management software, today announced a new strategic integration partnership with DentalHQ®, a premier patient membership management platform